Screening compound: InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3

Screening compound: InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3
Screening compound: InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T845-1770

Molecular Formula

C20H32N6O (C20 H32 N6 O)

Compound Name

2-(3-ethyl-2-methyl-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)-N~1~-methyl-N~1~-[(3-methyl-1-propyl-1H-pyrazol-5-yl)methyl]acetamide

IUPAC name

n/a

SMILES

CCCn1nc(C)cc1CN(C)C(CN(CC1)Cc2c1nc(C)n2CC)=O

MDL Number (MFCD)

InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3?
Check Price and Availability of InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C20H32N6O/c1-6-9-26-17(11-15(3)22-26)12-23(5)20(27)14-24-10-8-18-19(13-24)25(7-2)16(4)21-18/h11H,6-10,12-14H2,1-5H3 available by request